GT199800063A - Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros. - Google Patents

Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros.

Info

Publication number: GT199800063A
Authority: GT; Guatemala
Prior art keywords: dogs; inflammation; pain; treatment; carprophen
Prior art date: 1997-05-05

Application number

GT199800063A

Other languages

English (en)

Spanish (es)

Inventor

Kristin Marie Lundy

Anthony Paul Ricketts

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-05

Filing date

1998-05-04

Publication date

1999-10-26

1998-05-04 Application filed filed Critical

1999-10-26 Publication of GT199800063A publication Critical patent/GT199800063A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicinal Preparation (AREA)

GT199800063A 1997-05-05 1998-05-04 Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros. GT199800063A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US4563597P	1997-05-05	1997-05-05

Publications (1)

Publication Number	Publication Date
GT199800063A true GT199800063A (es)	1999-10-26

Family

ID=21939053

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GT199800063A GT199800063A (es)	1997-05-05	1998-05-04	Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros.

Country Status (32)

Country	Link
EP (1)	EP0988034A1 (pt)
JP (1)	JP2000513020A (pt)
KR (2)	KR20010012300A (pt)
CN (1)	CN1255059A (pt)
AP (1)	AP9801234A0 (pt)
AR (2)	AR011726A1 (pt)
AU (1)	AU6932198A (pt)
BG (1)	BG103852A (pt)
BR (1)	BR9808720A (pt)
CA (1)	CA2288759A1 (pt)
DZ (1)	DZ2479A1 (pt)
EA (1)	EA003696B1 (pt)
GT (1)	GT199800063A (pt)
HR (1)	HRP980244A2 (pt)
HU (1)	HUP0001286A3 (pt)
ID (1)	ID21311A (pt)
IL (1)	IL132570A0 (pt)
IS (1)	IS5220A (pt)
MA (1)	MA26491A1 (pt)
NO (1)	NO995389L (pt)
NZ (1)	NZ500183A (pt)
OA (1)	OA11213A (pt)
PA (1)	PA8450601A1 (pt)
PE (1)	PE72599A1 (pt)
PL (1)	PL337003A1 (pt)
SK (1)	SK148199A3 (pt)
TN (1)	TNSN98059A1 (pt)
TW (1)	TW590773B (pt)
UY (1)	UY24989A1 (pt)
WO (1)	WO1998050033A1 (pt)
YU (1)	YU55899A (pt)
ZA (1)	ZA983722B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6245797B1 (en)	1997-10-22	2001-06-12	Merck & Co., Inc.	Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) *	1998-05-22	2005-07-28	Pfizer Products Inc.	Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en)	1998-05-22	2003-01-14	Pfizer, Inc.	Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU764872B2 (en) *	1998-10-23	2003-09-04	Merck Frosst Canada & Co.	Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
CA2363590A1 (en) *	1999-03-10	2000-09-14	G.D. Searle & Co.	Method and composition for administering a cyclooxygenase-2 inhibitor
WO2001034204A1 (en) *	1999-11-11	2001-05-17	Eli Lilly And Company	Oncolytic combinations for the treatment of cancer
EP1283723A2 (en) *	2000-05-15	2003-02-19	Merck Frosst Canada & Co.	Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
RU2003100874A (ru)	2000-06-13	2004-06-27	Вайс (Us)	Болеутоляющие и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2
DE10032132A1 (de) *	2000-07-01	2002-01-17	Lohmann Therapie Syst Lts	Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
DE60137512D1 (de)	2000-08-07	2009-03-12	Univ Vanderbilt	Zusammensetzungen und verfahren zum nachweis und zur quantifizierung von cox-2-aktivität und 2-arachidonylglycerin-metaboliten
US20040209959A1 (en) *	2001-07-16	2004-10-21	Edward Hogestatt	Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
DK1534305T3 (da)	2003-05-07	2007-02-05	Osteologix As	Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte
MXPA06001288A (es) *	2003-07-31	2006-04-11	Upjohn Co	Formulacion dispersable de un agente anti-inflamatorio.
AU2006248645A1 (en) *	2005-05-20	2006-11-23	Pfizer Limited	Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
CN103120653B (zh)	2007-04-04	2015-09-30	希格默伊德药业有限公司	一种口服药物组合物
CA2942083C (en)	2007-04-26	2019-01-29	Sigmoid Pharma Limited	Manufacture of multiple minicapsules
SG176145A1 (en)	2009-05-18	2011-12-29	Sigmoid Pharma Ltd	Composition comprising oil drops
JP5911799B2 (ja)	2009-08-12	2016-04-27	シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄＰｈａｒｍａＬｉｍｉｔｅｄ	ポリマーマトリックスおよび油相を含んで成る免疫調節組成物
GB201020032D0 (en)	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
GB201212010D0 (en)	2012-07-05	2012-08-22	Sigmoid Pharma Ltd	Formulations
GB201319791D0 (en)	2013-11-08	2013-12-25	Sigmoid Pharma Ltd	Formulations
DK3113774T3 (da)	2014-03-06	2022-03-07	Elanco Animal Health Incorporated	Sammensætninger af grapiprant og fremgangsmåder til anvendelse deraf
PL3215127T3 (pl)	2014-11-07	2021-05-17	Sublimity Therapeutics Limited	Kompozycje zawierające cyklosporynę
US12109218B2 (en)	2014-12-09	2024-10-08	Aratana Therapeutics, Inc.	Compositions of grapiprant and methods for using the same
AU2016205145A1 (en) *	2015-01-09	2017-07-13	Jaguar Health, Inc.	Methods of treating diarrhea in companion animals
WO2021195346A1 (en) *	2020-03-25	2021-09-30	Sri International	Lipoxygenase inhibitors
US11116737B1 (en)	2020-04-10	2021-09-14	University Of Georgia Research Foundation, Inc.	Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko)	2020-11-30	2022-06-07	(주)이노보테라퓨틱스	벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3896145A (en) *	1972-07-24	1975-07-22	Hoffmann La Roche	Carbazoles
CA1319886C (en) *	1987-02-03	1993-07-06	Alberto Ferro	Mixed micelle solutions

1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/xx active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Application Discontinuation
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Application Discontinuation
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Application Discontinuation
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown

Also Published As

Publication number	Publication date
ID21311A (id)	1999-05-20
JP2000513020A (ja)	2000-10-03
MA26491A1 (fr)	2004-12-20
KR20040004406A (ko)	2004-01-13
NZ500183A (en)	2002-04-26
DZ2479A1 (fr)	2003-02-01
IL132570A0 (en)	2001-03-19
BG103852A (en)	2000-06-30
AR011726A1 (es)	2000-08-30
AP9801234A0 (en)	1999-11-04
HRP980244A2 (en)	1999-02-28
NO995389D0 (no)	1999-11-04
PA8450601A1 (es)	2000-05-24
TNSN98059A1 (fr)	2005-03-15
EP0988034A1 (en)	2000-03-29
WO1998050033A1 (en)	1998-11-12
OA11213A (en)	2003-07-14
HUP0001286A3 (en)	2000-12-28
CA2288759A1 (en)	1998-11-12
AU6932198A (en)	1998-11-27
TW590773B (en)	2004-06-11
CN1255059A (zh)	2000-05-31
BR9808720A (pt)	2000-07-11
EA003696B1 (ru)	2003-08-28
HUP0001286A2 (hu)	2000-11-28
EA199900895A1 (ru)	2000-06-26
KR20010012300A (ko)	2001-02-15
UY24989A1 (es)	2001-10-25
IS5220A (is)	1999-10-19
SK148199A3 (en)	2001-09-11
YU55899A (sh)	2003-08-29
PE72599A1 (es)	1999-08-12
AR039628A2 (es)	2005-03-02
ZA983722B (en)	1999-11-04
NO995389L (no)	2000-01-04
PL337003A1 (en)	2000-07-31

Publication	Publication Date	Title
GT199800063A (es)	1999-10-26	Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros.
GT199800021A (es)	1999-07-22	Utilizacion de antagonistas de los receptores de canabinoides centrales para la preparacion de medicamentos.
GT200100211AA (es)	2004-11-30	Compuestros de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgesicos. (patentefraccionaria no. 1 de la solicitud de patente de invencion no. pi-2001-0211.
ECSP066575A (es)	2006-10-17	Antagonistas del receptor b1 de bradiquinina
CL2008003941A1 (es)	2009-05-22	Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo.
ES2194732T3 (es)	2003-12-01	Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
CU23226B7 (es)	2007-09-26	COMPOSICIONES ANALGéSICAS QUE COMPRENDEN COMPUESTOS ANTI-EPILéPTICOS Y ANTINFLAMATORIOS NO ESTEROIDEOS
GT199700089A (es)	1999-01-26	Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido.
GT199800171A (es)	2000-04-21	Inhibidores selectivos directos o indirectos del factor xa.
ES2194536T3 (es)	2003-11-16	Combinacion de duloxetina con farmacos antiinflamatorios no esteroideos.
CL2004000674A1 (es)	2005-01-07	Sistema terapeutico transdermico que comprende al menos una sustancia activa farmaceutica, al menos un disruptor de la estructura y/o al menos un formador de estructura en una matriz comun.
UY27511A1 (es)	2003-04-30	Nuevos agentes andidiabéticos
AR027091A1 (es)	2003-03-12	Forma de dosificacion de farmacos accionada por un hidrogel
CO5611096A2 (es)	2006-02-28	Forma de dosificacion farmaceutica para administracion mucosal
DE69532415D1 (de)	2004-02-12	Schmelzextrudierte oral verabreichbare opioidformulierungen
ATE312602T1 (de)	2005-12-15	Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
UY27296A1 (es)	2003-04-30	Composición farmacéutica que contiene mosaprida y pancreatina
ES2171933T3 (es)	2002-09-16	Derivados de androsteno.
GT199800205A (es)	2000-06-21	Compuestos de indol 2,3-sustituidos como agentes anti-inflamatorios y analgesicos.
ES2221950T3 (es)	2005-01-16	Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
ATE212829T1 (de)	2002-02-15	Feste, wasserfreie, pharmazeutische zubereitungen für vaginale verwendung
AR030957A1 (es)	2003-09-03	Composiciones de analgesico y glucosamina
ECSP034858A (es)	2004-01-28	Administración oral de hormona paratiroides y calcitonina
GT199800039A (es)	1999-08-13	Atropisomeros de 3-heteroaril-4(3h)-quinazolinonas.
AR030662A1 (es)	2003-08-27	Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos